成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 305834-79-1 Chemical Structure| 305834-79-1
Chemical Structure| 305834-79-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 305834-79-1

,{[proInfo.pro_purity]}

SC79 is a specific Akt agonist capable of crossing the blood-brain barrier. It activates cytosolic Akt and inhibits Akt membrane translocation by specifically binding to the PH domain of Akt.

Synonyms: SC79

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of SC-79

CAS No. :305834-79-1
Formula : C17H17ClN2O5
M.W : 364.78
SMILES Code : O=C(OCC)C(C#N)C1C(C(OCC)=O)=C(N)OC2=CC=C(Cl)C=C12
Synonyms :
SC79
InChI Key :DXVKFBGVVRSOLI-UHFFFAOYSA-N
Pubchem ID :2810830

Safety of SC-79

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of SC-79

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description Reference
AML12 cells 5 μg/ml 24 h To study the effect of SC-79 on AML12 cells, results showed that SC-79 activated the Akt2 signaling pathway. PMC9421584
Mesenchymal Stem Cells (MSCs) 0, 10, 20, 30 μM 24 h To evaluate the effect of DFO on MSC activity, results showed that DFO treatment significantly inhibited KDM4D enzyme activity, hindering MSC activation PMC11335281
EndoC-βH1 cells 8 μg/mL 48 h SC79 increased PDX1 protein levels, but METTL3 silencing blocked this increase, indicating that m6A regulates PDX1 protein levels synergistically with AKT. PMC6924515
SCC9 cells 5 μg/mL Activate AKT, partially reverse the effects of METTL1 knockout on HNSCC cells PMC8923133
SCC15 cells 5 μg/mL Activate AKT, partially reverse the effects of METTL1 knockout on HNSCC cells PMC8923133
MHCC-97H cells 4 μg/ml 1 h SC79 partially restored the suppressed effect on cell proliferation induced by YTHDF1 inhibition PMC8176587
Primary leiomyoma cells 10 μM 15 min, 30 min, 60 min, 120 min, 360 min SC79 treatment enhanced AKT phosphorylation after 30 min treatment and reached significance after 1h. β-catenin phosphorylation at Ser 552 increased at 30 min and peaked at two h post-treatment, which was accompanied by increased levels of active β-catenin (non-phosphorylated β-catenin at Ser 45) and its downstream target, Axin2. PMC7722234
MCF-7 cells 5 μg/mL 1 h To test the effect of SC-79 on the AKT signaling pathway, results showed that SC-79 activated the AKT signaling pathway. PMC5453322
MH-S cells 10 nM 4 h SC-79 was used as an Akt activator to study its effect on signaling pathway activation in MH-S cells. PMC6637737

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
Mice Col2a1-cre; Mapk7f/fmouse model Intraperitoneal injection 0.04 mg/g Once daily for 8 weeks Activated the AKT signaling pathway, partially alleviating the impaired chondrocyte hypertrophy and vertebral defects caused by Mapk7 deletion. PMC10491872
mice C57BL/6J mice intraperitoneal injection 20 mg/kg once a week for 14 days To study the effect of SC-79 on liver fat deposition in mice, results showed that SC-79 enhanced Akt2 activity, leading to increased liver fat deposition. PMC9421584
C57BL/6 male mice Iron deficiency mouse model Intraperitoneal injection 20 mg/kg Every 5 days for one month To evaluate the effect of SC-79 on bone density in iron-deficient mice, results showed that SC-79 significantly reversed the bone density decline caused by iron deficiency PMC11335281
mice Mettl1cKO mice intraperitoneal injection 0.04 mg/g 4 weeks after 4NQO treatment and fed for 20 weeks Activate AKT, increase the lesion number, lesion area, malignancy, proliferation, and metastasis of HNSCC in Mettl1cKO mice PMC8923133
C57BL/6 mice Bleomycin-induced pulmonary fibrosis model Intraperitoneal injection 40 mg/kg Once daily for 3 days SC-79 significantly improved bleomycin-induced pulmonary fibrosis symptoms, including tissue pathological changes, collagen deposition, and loss, by activating the AKT signaling pathway. PMC8514558

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.74mL

0.55mL

0.27mL

13.71mL

2.74mL

1.37mL

27.41mL

5.48mL

2.74mL

References

 

Historical Records

Categories